Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
252.4 INR | +4.99% |
|
+27.56% | 0.00% |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net sales 1 | 5.383 | 18.25 | 34.24 | 182.1 |
EBITDA 1 | 0.1022 | 1.802 | 0.8067 | 33.68 |
EBIT 1 | 0.1015 | 1.673 | -0.3076 | 25.84 |
Operating Margin | 1.88% | 9.17% | -0.9% | 14.19% |
Earnings before Tax (EBT) 1 | -0.1481 | 1.528 | -0.4628 | 25.77 |
Net income 1 | -0.1478 | 1.351 | -5.51 | 23.73 |
Net margin | -2.75% | 7.41% | -16.09% | 13.03% |
EPS 2 | -0.7390 | 6.757 | -0.5510 | 2.372 |
Free Cash Flow | - | - | - | 34.2 |
FCF margin | - | - | - | 18.78% |
FCF Conversion (EBITDA) | - | - | - | 101.55% |
FCF Conversion (Net income) | - | - | - | 144.16% |
Dividend per Share | - | - | - | - |
Announcement Date | 10/11/21 | 10/11/21 | 30/09/22 | 04/09/23 |
Balance Sheet Analysis
Fiscal Period: Maart | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net Debt 1 | 3.47 | 2.05 | 19.4 | 1.65 |
Net Cash position 1 | - | - | - | - |
Leverage (Debt/EBITDA) | 33.9 x | 1.139 x | 24.06 x | 0.0489 x |
Free Cash Flow | - | - | - | 34.2 |
ROE (net income / shareholders' equity) | - | 90.4% | -295% | 177% |
ROA (Net income/ Total Assets) | - | 10.1% | -0.64% | 24.8% |
Assets 1 | - | 13.39 | 864.2 | 95.54 |
Book Value Per Share 2 | 4.100 | 10.90 | 0.1600 | 2.530 |
Cash Flow per Share 2 | 2.050 | 24.10 | 0.6100 | 2.320 |
Capex | - | - | - | 5.05 |
Capex / Sales | - | - | - | 2.77% |
Announcement Date | 10/11/21 | 10/11/21 | 30/09/22 | 04/09/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- NEPHROCARE Stock
- Financials Nephro Care India Limited